Search
phendimetrazine (Mephenmetrazine)
DEA-controlled substance: class 3.
Dosage:
1) 35 mg PO before meals
2) 105 mg of slow release form daily
3) 17.5-105 mg QD (divided TID or QD (slow release)
Pharmacokinetics:
1) metabolized in liver to largely inactive metabolites
2) metabolites excreted by the kidney
3) 1/2 life: 5-12 hours
Adverse effects:
1) insomnia
2) agitation
3) nervousness
4) hyperthermia
5) hyperventilation
6) hypertension
7) convulsions
Interferences:
-> may cause false positives in immunoassays for amphetamines in urine
Mechanism of action:
1) CNS stimulant
2) appetite suppressant
Interactions
drug adverse effects (more general classes)
General
adrenergic neuron stimulant
amine
analeptic (CNS stimulant)
aromatic compound
Properties
MISC-INFO: elimination route LIVER
KIDNEY
1/2life 5-12 HOURS
therapeutic-range 30-250 NG/ML
toxic-range >1 UG/ML
Database Correlations
PUBCHEM correlations
References
- Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed.,
W.B. Saunders, 1995
- Harrison's Principles of Internal Medicine, 14th ed.
Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 461